Sana Biotechnology Inc vs Sony Group Corp — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Sony Group Corp trades at $21.11 (market cap $125.96B). The key difference: Sony Group Corp is far larger — about 144.1× Sana Biotechnology Inc's market cap, and Sony Group Corp pays a 0.75% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SONY | |
|---|---|---|
Market Cap | $873.84M | $125.96B |
Sector | Health | Technology |
52-Week High | $5.92 | $30.26 |
52-Week Low | $2.68 | $19.32 |
Enterprise Value | $848.03M | $122.45B |
Dividend Yield | — | 0.75% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →